InvestorsHub Logo
Followers 25
Posts 2345
Boards Moderated 0
Alias Born 06/20/2020

Re: 10nisman post# 31586

Friday, 07/30/2021 12:34:39 PM

Friday, July 30, 2021 12:34:39 PM

Post# of 42553

This is Cameron telling the street their discussions with the FDA have lead to no EUA approval and HGEN needed to expand the ACTIV-5 trial size in hopes of having enough support for the BLA.


They wouldn't have expanded the trial is they weren't going to give an EUA. They made the decision to approve lenz and then expanded the ACTIV-5 so that they have enough support for the BLA.